MBX Biosciences, Inc. MBX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $18.47M-17.5% | $19.76M+29.8% | $19.27M+15.1% | $17.72M+23.1% | $22.41M+103% | ||
| $8.79M+113% | $6.04M+78.2% | $4.66M+62.5% | $4.08M+80.4% | $4.12M+82.1% | ||
| $27.27M+2.8% | $25.8M+38.6% | $23.93M+22.0% | $21.81M+30.9% | $26.53M+99.3% | ||
| -$27.27M-2.8% | -$25.8M-38.6% | -$23.93M-22.0% | -$21.81M-30.9% | -$26.53M-99.3% | ||
| -$23.52M+1.5% | -$22.09M-41.7% | -$21.62M-19.2% | -$19.41M-22.4% | -$23.88M-93.6% | ||
| -$0.50+29.6% | -$0.45— | -$0.63+77.3% | -$0.58+95.4% | -$0.71+93.1% | ||
| -$27.2M-2.8% | -$25.74M-38.7% | -$23.83M-22.1% | -$21.71M-31.1% | -$26.45M-99.4% | ||
| -$27.27M-2.8% | -$25.8M-38.6% | -$23.93M-22.0% | -$21.81M-30.9% | -$26.53M-99.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is MBX Biosciences, Inc. profitable?
- MBX Biosciences, Inc. is not currently profitable: it reported a net loss of $86.6M over the trailing twelve months.
- What is MBX Biosciences, Inc.'s earnings per share?
- MBX Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.16.
- Where does MBX Biosciences, Inc.'s income statement data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.